EDWIN HORWITZ, MD

Plain English
This study looked at the relationship between side effects from radiation therapy for prostate cancer and the return of cancer signals in patients. Researchers analyzed data from 7 trials involving over 6,700 men. They found that 17% of patients had cancer return, while 14.3% experienced significant gastrointestinal issues and 15.5% had serious urinary problems after treatment. Interestingly, those with more gastrointestinal problems had a lower chance of cancer returning, suggesting a complex relationship that researchers believe might be linked to how the prostate moves during treatment. Who this helps: This helps patients undergoing prostate cancer radiation therapy.

Plain English
This study focused on creating a clear definition for mesenchymal stromal cells (MSCs) and reporting guidelines for studies that use these cells in treatments. The researchers gathered insights from 87 experts across three rounds of surveys and discussions, ultimately agreeing on nine key characteristics that define MSCs and 33 essential items that should be reported in clinical studies. This is important because it will help standardize MSC research, making it easier for doctors and scientists to understand and compare results. Who this helps: This benefits researchers and healthcare professionals working with MSC-based therapies.

Plain English
This study looked at how well a combination treatment called tixagevimab-cilgavimab (T-C) works to prevent severe COVID-19 in patients with blood cancers who are receiving a specific type of therapy (anti-CD20). Among 749 patients studied, those who received T-C experienced significantly fewer cases of COVID-19 (11.2%) compared to those who did not receive it (23.4%). T-C also reduced severe cases of COVID-19 from 5.2% to 1.4%, showing it can effectively protect vulnerable patients during COVID-19 waves, even though it may not work against current variants. Who this helps: This helps patients with blood cancers undergoing anti-CD20 therapy.

Plain English
This study analyzed data from six clinical trials involving 6,593 patients who received prostate radiotherapy. It found that experiencing early side effects (acute toxicity) significantly increased the chances of having long-term side effects (late toxicity) and decreased quality of life, with odds ratios of 2.20 for urinary issues and 2.53 for gastrointestinal problems. Understanding this relationship is important because it highlights the need to develop ways to minimize early side effects, which could help improve long-term patient outcomes. Who this helps: This helps patients undergoing prostate cancer treatment.

Plain English
This study looked at a genetic variant (rs5491) in Black individuals that might increase the risk of heart failure, specifically a type called heart failure with preserved ejection fraction (HFpEF), in people with chronic kidney disease (CKD). Among 1,267 participants, those with this genetic variant had a 35% higher risk of developing HFpEF over an average of 10.3 years. Understanding this relationship is important because it helps identify individuals with CKD who are at greater risk for a specific type of heart failure, allowing for earlier intervention. Who this helps: Patients with chronic kidney disease and their healthcare providers.

Plain English
This study looked at how genes are organized and interact within cells in three dimensions, rather than just as flat images. Researchers developed a new tool, 3D-spaGNN-E, that helped them find key interactions between genes in different types of cells, like stem cells and immune cells. They discovered specific gene proximity changes that indicate how cells communicate and regulate each other; for instance, they found differences between strong and weak immune responses while studying cells in various environments. Who this helps: This benefits researchers and doctors by providing insights into cell communication that could improve treatments for diseases like cancer or autoimmune disorders.

Plain English
This study examined how different types of hypofractionated radiotherapy (MHFRT) for prostate cancer compare with traditional radiotherapy (CFRT) in terms of effectiveness and side effects. The researchers analyzed data from seven trials involving a total of 5,880 patients and found that both MHFRT and CFRT had similar rates of cancer progression, but grade 2 or higher bowel side effects were more common with a stronger dose of MHFRT. The findings suggest that using a moderate dose of MHFRT (like 60 Gy in 20 sessions) can effectively treat localized prostate cancer while minimizing some side effects compared to higher doses. Who this helps: This benefits prostate cancer patients seeking effective treatment with fewer side effects.

Plain English
This study looked at how breast cancer cells in the bloodstream (called circulating tumor cells or CTCs) respond to the chemotherapy drug docetaxel (DTX). Researchers found that in some cases, DTX completely killed the cancer cells, while in others, a new group of drug-tolerant cancer cells emerged that could survive and grow again. Specifically, when CDKN1B (a protein) was active, it helped these cells avoid becoming too many copies of themselves, which allowed them to resist the effects of the drug. Who this helps: This research benefits patients with advanced breast cancer, providing insights for better treatment strategies.

Plain English
This study looked at the long-term effects of lowering blood pressure very aggressively on kidney health in people who participated in the SPRINT trial. It found that during the aggressive treatment phase, kidney function declined more sharply—by 0.96 ml/min per year for those receiving intensive treatment compared to 0.67 ml/min for those getting standard treatment. However, after the trial ended, the decline in kidney function was similar for both groups, which means that the intense treatment's negative impact was mostly temporary. Who this helps: This research benefits patients with high blood pressure and healthcare providers managing their treatment strategies.

Plain English
This study looked at how COVID-19 affects patients with blood cancers treated with two different medications: obinutuzumab and rituximab. It found that among 1,048 patients, those treated with obinutuzumab were 2.08 times more likely to experience severe or critical COVID-19 symptoms compared to those treated with rituximab, despite being younger and having less aggressive cancer. This is important because it highlights potential risks of using obinutuzumab during viral outbreaks, which could influence treatment decisions. Who this helps: This research benefits patients with blood cancers and their doctors by informing treatment choices.

Plain English
This study looked at a method for treating prostate cancer called high dose rate brachytherapy (HDR-BT), specifically using an ultrasound-based workflow. The researchers found that their new method consistently provided excellent treatment outcomes, achieving a prostate coverage rate of 98.9% and keeping damage to nearby organs very low, with minimal exposure to the rectum and bladder. These findings are important because they show that this approach not only effectively targets the cancer but also protects surrounding healthy tissues, leading to safer treatments for patients. Who this helps: This helps patients undergoing prostate cancer treatment by improving their treatment outcomes and reducing side effects.

Plain English
This research studied how health literacy affects the health outcomes of adults with chronic kidney disease (CKD). It found that out of 3,715 participants, those with limited health literacy (about 15%) had a greater risk of CKD progression (34% more likely), cardiovascular events (67% more likely), hospitalizations (33% more likely), and death from any cause (54% more likely). Understanding health information is crucial because those who struggle with it are more likely to face severe health issues and complications. Who this helps: This helps patients with chronic kidney disease and their healthcare providers.

Plain English
This study looked at how autistic symptoms and related mental health issues show different patterns in boys and girls with autism, compared to a similar group of teens without autism. Researchers found that boys with autism showed more issues with repetitive behaviors and resistance to change, but by the end of adolescence, girls with autism experienced a rise in these issues as well. Additionally, girls without autism reported increasing mood and anxiety problems over time, showing that sex differences in mental health exist even outside of autism. Who this helps: This research benefits doctors and mental health professionals treating adolescents with autism and related issues.

Plain English
This study looked at how depressive symptoms change over time in people with mild-to-moderate chronic kidney disease (CKD) and how these symptoms relate to the progression of their kidney function. Researchers found that 9.2% of participants had consistently high depressive symptoms, and those with moderate to high symptoms were more likely to experience a rapid decline in kidney function; specifically, the chances were 1.45 times higher for those with moderate symptoms and 1.90 times higher for those with high symptoms. Understanding this connection is important because it highlights the need for better mental health support in CKD patients to potentially slow down kidney decline. Who this helps: This helps patients with chronic kidney disease.

Plain English
This study examined how adjusting the levels of a protein called Rap1 affects the expression of various genes in yeast. The researchers found that when Rap1 levels were lowered, it activated more genes than it repressed, particularly ribosomal protein genes, but surprisingly repressed genes involved in breaking down sugars. Understanding how Rap1 works is important because it helps clarify how gene regulation can impact processes like growth and health, which can have implications for both evolution and diseases in humans. Who this helps: This research benefits scientists studying gene regulation and its effects on health and disease.

Plain English
This study examined the use of BCMA CAR-T therapy in a young patient with a rare type of aggressive lymphoma called plasmablastic lymphoma, which did not respond to traditional treatments. The patient achieved complete remission within 15 days of receiving the CAR-T therapy and has remained cancer-free for over a year, with no severe side effects. This finding is significant because it suggests a potential new treatment option for patients with this difficult-to-treat cancer. Who this helps: This helps patients with refractory plasmablastic lymphoma.

Plain English
This study looked at 195 medications to see how likely they are to harm the kidneys in patients who are not in intensive care. The researchers found that only 14 medications are safe in almost all cases, while 39 were removed from the list due to uncertainty about their effects. This information is important because it helps doctors understand which drugs pose a risk to kidney health, allowing for better treatment choices. Who this helps: This helps doctors and pharmacists in making safer medication decisions for their patients.

Plain English
This study looked at whether children undergoing a specific type of stem cell transplant could safely use shorter courses of antibiotics when they experienced their first fever. The researchers aimed to cut the use of these broad-spectrum antibiotics from an average of 20 days down to 10 days and found that they could reduce it to 10 days for eligible patients, with significant improvements: from 17 days to 8 days for the first fever and from 20 days to 10 days overall. This is important because it may help reduce the risk of antibiotic-related complications and resistance without compromising patient safety. Who this helps: This helps children undergoing allogeneic hematopoietic cell transplantation and their doctors by potentially minimizing antibiotic use and its side effects.

Plain English
This study looked at how tightly controlling blood pressure affects kidney issues (acute kidney injury or AKI) and overall health outcomes. Researchers found that more kidney problems occurred in patients with intensive blood pressure treatment, with 187 cases compared to 155 in standard treatment. AKI was linked to a higher risk of dying from all causes, emphasizing the need for careful management to prevent kidney damage while controlling blood pressure. Who this helps: This helps patients with high blood pressure and their doctors in managing treatment plans.

Plain English
This study looked at how body fat and physical fitness affect health risks in people with chronic kidney disease (CKD). Researchers found that higher amounts of fat in the body, especially around the belly and liver, were linked to worse health outcomes, such as increased resistance to insulin and higher levels of harmful substances in the blood. For instance, more belly fat was associated with lower good cholesterol levels and higher triglycerides, which can worsen heart and kidney problems. Who this helps: This research benefits patients with chronic kidney disease by highlighting the importance of managing body fat and physical activity for better health outcomes.

Plain English
This study looked at patients with kidney-related high parathyroid hormone levels who had surgery to remove their parathyroid glands. Out of 68 patients, 26% had extra (ectopic) glands, mostly found in the thymus, and 16% had more than the usual number of glands. After surgery, around 6% of patients continued to have high hormone levels, and about 9% had a return of the problem, showing the importance of thorough surgical techniques to improve patient outcomes. Who this helps: This research benefits patients with kidney issues and their doctors by improving surgical strategies.

Plain English
This study looked at factors that influence the progression of chronic kidney disease (CKD) in nearly 5,500 adults in the U.S. Over ten years, researchers identified several key risk factors, including social and economic conditions, lifestyle choices, genetics, heart health, and other metabolic and injury-related markers. Understanding these factors helps improve care for CKD patients and identify those at higher risk of worsening kidney health. Who this helps: This benefits patients with chronic kidney disease and their healthcare providers.

Plain English
This study looked at how having social support affects older adults with chronic kidney disease (CKD). Researchers found that about 22% of participants had low social support, and those with stronger social networks reported better health-related quality of life, improved cognitive function, and were less likely to be frail. Specifically, for every increase in social support score, there was a notable improvement in health measures, indicating that being connected with others can lead to better overall health for these patients. Who this helps: This benefits older adults with CKD and their caregivers.

Plain English
This study developed a web-based tool to help prostate cancer patients make informed choices about their treatment by considering their personal preferences and health goals. The tool assesses various treatment options based on factors like side effects and the chances of treatment success, allowing patients to see which options best match their needs. Early feedback shows that every treatment could be the best choice for different patients, emphasizing that personalized approaches can improve patient satisfaction and treatment adherence. Who this helps: This benefits prostate cancer patients by providing them with a clearer understanding of their treatment options.

Plain English
This research studied how certain cancer cells, called circulating tumor cells (CTCs), survive in the bloodstream of melanoma patients and develop resistance to treatments. The researchers found that these cells use a regulator called SREBP2 to increase levels of a protein called transferrin, which helps manage iron in the cells, ultimately making them more resilient to both treatment and stressors that typically kill cancer cells. Specifically, patients whose CTCs showed high activity in these pathways had worse outcomes, regardless of the treatment they were receiving. Who this helps: This information benefits melanoma patients by highlighting potential targets for new treatments.

Plain English
This study examined how a protein called NR4A1 affects cancer cells, specifically their ability to handle stress when they are rapidly dividing. Researchers found that when NR4A1 is present, it helps control the activation of certain genes related to stress response, preventing problems that can lead to cell instability. When NR4A1 is removed, cancer cells have significant issues with their chromosomes and can’t grow properly. This is important because about half of breast and other cancers show signs that they rely on NR4A1 for survival and growth. Who this helps: This helps cancer patients and doctors understand a potential target for improving treatments.

Plain English
This study examined how certain minerals in the body change over time in patients with chronic kidney disease (CKD) as they approach end-stage kidney disease (ESKD). Researchers found that levels of a protein called FGF-23 increased significantly, starting about 5 years before patients reached ESKD, showing the biggest changes among the minerals studied. Understanding these changes is important because it can help doctors identify patients who are likely to progress to ESKD sooner, allowing for earlier intervention. Who this helps: Patients with chronic kidney disease at risk of progressing to end-stage kidney disease.

Plain English
This study looked at how certain inflammatory markers in the blood relate to the risk of being hospitalized for infections in people with chronic kidney disease (CKD). Researchers found that higher levels of the markers IL-6 and TNF-α were linked to a greater chance of hospitalization: patients in the highest 5% for IL-6 were more than twice as likely to be hospitalized for infections compared to those in the lowest 5%, while the risk for TNF-α was nearly double as well. Understanding this relationship could help improve care and prevention strategies for CKD patients at risk of serious infections. Who this helps: This helps patients with chronic kidney disease and their healthcare providers.

Plain English
This study examined how race affects survival rates among patients with chronic kidney disease (CKD) on dialysis, focusing on differences between black and white individuals. Researchers followed 3,288 participants for about 7 years and found that black patients had a 33% lower risk of death after starting dialysis compared to white patients. However, when considering overall mortality from the beginning of the study, black patients showed a higher risk of death than whites, though this difference lessened when taking into account other health factors. Who this helps: This research helps doctors and healthcare providers understand racial disparities in survival among kidney disease patients, leading to better treatment plans.

Plain English
This study looked at how a specific type of weight loss surgery, called sleeve gastrectomy, affects the levels of HIV medications in severely obese patients. After the surgery, the levels of the drug abacavir in a patient increased about 12 times compared to before the surgery, while other HIV medications also showed higher levels. This is important because it indicates that patients may need their medication doses adjusted after such surgery to avoid potential side effects or drug toxicity. Who this helps: This information benefits HIV patients who undergo weight loss surgery and their doctors managing their treatment.

Plain English
This research compared two treatments for men with recurrent prostate cancer after initial radiation therapy: cryotherapy (freezing the cancer) and hormone therapy (androgen deprivation therapy, or ADT), which lowers testosterone levels. The study included 169 patients for each treatment option, finding that those who received cryotherapy lived longer on average—12.3 years compared to 10.2 years for those on ADT—though the chance of dying from prostate cancer after 10 years was similar for both groups (18.5% for ADT vs. 16.2% for cryotherapy). These findings are important because they suggest that cryotherapy might offer longer overall survival without worsening the cancer-related death rate, highlighting a possible better treatment option for patients. Who this helps: Patients with recurrent prostate cancer.

Plain English
This study examined how having a specific protein in urine (albuminuria) affects the benefits of lowering blood pressure in older adults at high risk for heart problems. Researchers found that over about 3 years, only 4% of participants with albuminuria experienced significant kidney function decline compared to just 1% of those without it. The study showed that lowering blood pressure intensively was helpful for everyone, regardless of whether they had albuminuria, suggesting all patients can benefit from aggressive blood pressure management. Who this helps: This helps patients with high blood pressure, including those with kidney issues.

Plain English
This study looked at whether blood pressure readings from regular doctor visits match those taken in a controlled research setting known as the SPRINT trial. Researchers found that blood pressure measured during routine clinical practice was generally higher—by an average of 7.3 mm Hg in the intensive treatment group—than the SPRINT trial measurements, indicating that the way blood pressure is measured in everyday settings may not be as reliable. This matters because discrepancies in blood pressure readings can affect treatment decisions for patients with high blood pressure. Who this helps: This helps doctors and patients managing hypertension.

Plain English
This study looked at how patients, pharmacists, and doctors in the Netherlands experience the use of pharmacogenomic screening, which helps tailor medication based on a person's genetic makeup. Out of 165 patients, 58 pharmacists, and 21 physicians surveyed, they found that while there was a general positive attitude toward this type of screening, many faced challenges such as insufficient education, reliance on computer systems, and unclear responsibilities about who should discuss results with patients. These barriers need to be addressed to make pharmacogenomic screening more effective and accessible, which can improve patient care and possibly lower healthcare costs. Who this helps: Patients and healthcare providers benefit from improved understanding and implementation of personalized medicine.

Plain English
This study explored a treatment called low-dose-rate (LDR) brachytherapy for men with locally recurring prostate cancer after they had received external beam radiation therapy (EBRT). Researchers followed 92 patients for about 4 to 97 months and found that only 14% experienced severe side effects (grade 3) related to the treatment, which is below the 20% threshold considered unacceptable. This is important because it shows that LDR brachytherapy can be a safe option for managing prostate cancer recurrences without a high risk of harmful side effects. Who this helps: This helps men with prostate cancer who have had a recurrence after previous radiation treatment.

Plain English
This study focused on a specific antibody, called hNKp46.02, that can target and regulate a receptor (NKp46) on natural killer (NK) cells, which play a key role in fighting cancer and infections, as well as in certain autoimmune diseases like type 1 diabetes. The researchers discovered that this antibody effectively decreases NKp46 activity, allowing them to identify important disease-related targets, including certain cancer cells and pancreatic beta cells crucial for diabetes. Notably, they found that the antibody can also be linked to a toxin to inhibit the growth of harmful cells, highlighting its potential use as a treatment for diseases reliant on NKp46. Who this helps: This benefits patients with type 1 diabetes and certain cancers, as well as the doctors treating them.

Plain English
This study looked at how to manage patients taking direct oral anticoagulants (DOACs) who were also using drugs that boost enzyme activity, which can reduce the effectiveness of DOACs. Researchers found that in a group of 1,596 hospitalized patients on DOACs, only 22 (1.4%) were also taking these enzyme-inducing drugs, and many had low levels of DOACs in their system. This matters because if DOAC levels are too low, patients may not receive adequate treatment for their conditions, so measuring these drug levels could help ensure better management for those taking both types of medications. Who this helps: Patients on DOACs who also need to take enzyme-inducing drugs.

Plain English
This study looked at how different types of fats in the blood, called lipids and apolipoproteins, are related to the risk of heart disease in people with chronic kidney disease (CKD). The researchers found that individuals with high levels of very low-density lipoprotein cholesterol (VLDL-C) and apolipoprotein B (Apo-B), as well as low levels of high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (Apo-AI), had an increased risk of heart-related events, such as heart attacks or strokes. Specifically, those with the highest VLDL-C had a 28% higher risk, and those with low HDL-C had a risk that was 40% to 77% higher compared to other groups. Who this helps: This information is valuable for patients with chronic kidney disease and their doctors in managing their heart health.

Plain English
This study looked at how a hospital program led by clinical pharmacists improved the safe use of blood thinners called direct oral anticoagulants (DOACs) among hospitalized patients. Out of 585 patients receiving DOACs, pharmacists identified drug-related problems in over one-third and provided recommendations, with more than 70% of these suggestions being accepted by doctors. This is important because it helps reduce the risks associated with improper dosing and ensures safer treatment for patients who need these medications. Who this helps: This helps patients who are prescribed DOACs, ensuring they receive safer and more effective care during their hospital stay.

Plain English
This study looked at how antibiotics, particularly second-line antibiotics, are used in the community healthcare system in Israel. Researchers found that in 2016, the rate of antibiotic prescriptions was 20.76 daily doses per 1,000 people, with second-line antibiotics making up 22% of the total prescriptions. This usage has remained high and stable since 2014, particularly among older individuals, women aged 20-40, and people with lower socioeconomic status, which highlights the need for better monitoring and management of antibiotic use to prevent drug resistance. Who this helps: This benefits patients by promoting safer antibiotic use and reducing the risk of antibiotic resistance.

Plain English
This study looked at how the surrounding tissue (stroma) affects the structure of pancreatic cancer tumors. The researchers found that certain cell types within the tumors, specifically invasive and rapidly growing cells, were linked to specific signaling pathways and were present in different amounts across 195 tumor samples. They identified over 319,000 individual cancer cells, revealing that the variety in tumor structure is connected to how much stroma is around the tumor, which impacts patient outcomes. Who this helps: This research benefits patients with pancreatic cancer by improving understanding of tumor behavior and potentially guiding treatment decisions.

Plain English
This study looked at how a specific type of prostate cancer cell pattern, called Gleason pattern 5 (GP5), affects patient outcomes after treatment with hormone therapy and radiation. Researchers found that patients with a Gleason score of 8-10 who also had GP5 were significantly more likely to develop distant metastasis (cancer spreading to other parts of the body), with an 11% higher risk after ten years compared to those with a lower Gleason score. Understanding the risk associated with GP5 can help doctors provide better treatment plans tailored for patients with more aggressive cancer. Who this helps: Patients with high-risk prostate cancer.

Plain English
This study looked at how low diastolic blood pressure (DBP) affects the benefits of aggressive blood pressure treatment in older adults. Researchers found that while lower baseline DBP was linked to a higher risk of heart problems, the aggressive treatment did not show different benefits based on DBP levels; for instance, there was a 22% lower risk of heart issues with intensive treatment compared to standard treatment, regardless of DBP. This matters because it helps clarify that aggressive blood pressure control can be helpful even for individuals with low DBP. Who this helps: This helps older adults with high blood pressure and their doctors.

Plain English
Researchers created a new tool called the Cancer Care Index (CCI) to track and reduce negative events in pediatric cancer care, leading to a 42% improvement in patient outcomes. They then applied similar tools to other medical services, including kidney care, lung transplants, and tracheostomy care, resulting in significant reductions in negative events: 63.2% for kidney care, 89.5% for lung transplantation, and 53.0% for tracheostomy care. This improvement matters because it shows that using specific metrics can help hospitals provide safer, more effective care for children. Who this helps: This benefits pediatric patients and their healthcare providers.

Plain English
This study looked at how sleeve gastrectomy, a type of weight loss surgery, affects blood sugar control in obese mice with diabetes. The researchers found that just one week after surgery, these mice had lower blood sugar levels even though they had only lost a small amount of weight (5%). Overall, the surgery improved how the body responded to insulin without relying on weight loss, showing that sleeve gastrectomy can directly enhance blood sugar control. Who this helps: This research benefits people with obesity and diabetes considering weight-loss surgery.

Plain English
This study looked at how damage to the DNA in pancreatic cells, called β-cells, might lead to inflammation seen in Type 1 diabetes (T1D). Researchers found that this DNA damage is common in patients recently diagnosed with T1D and linked to the presence of immune cells attacking the pancreas. They also discovered that blocking a specific DNA repair gene in mice reduced inflammation and prevented high blood sugar levels, suggesting that addressing DNA damage could be important in treating T1D. Who this helps: This research benefits patients with Type 1 diabetes by offering new insights into potential treatments.

Plain English
This study looked at how a hormone called gastrin, usually only found during development, appears in the pancreas of people and mice with type 2 diabetes. The researchers found that in diabetic mice, gastrin shows up in insulin-producing cells, while in humans with type 2 diabetes, it appears in both insulin and another type of cell. They discovered that high blood sugar triggers this change in some insulin-producing cells, but reducing sugar levels quickly stops gastrin production. This finding highlights gastrin as a key indicator of changes in pancreatic cells in diabetes. Who this helps: This helps patients with type 2 diabetes and their healthcare providers.

Plain English
This study examined the risks faced by people with advanced chronic kidney disease (CKD) and aimed to understand how different factors influence their chances of serious problems like kidney failure, heart disease, or death. Researchers tracked 1,798 patients over about 5.5 years and found that more than half (52.3%) progressed to kidney failure, but the specific risks differed based on individual traits. For example, a 60-year-old white woman had a 3.3% chance of developing heart disease in one year, while a 40-year-old African American man had a 13.2% chance of reaching kidney failure, showing how personal factors can change risk levels. Who this helps: This information is beneficial for patients and doctors managing chronic kidney disease, enabling more tailored treatment plans.